Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Malissen

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Annales De Dermatologie Et De Venereologie|May 20, 2014
[Multiple primary cutaneous plasmacytoma]N Malissen, C Fabre, J-M Joujoux, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 8, 2019
Comparison of complementary and alternative medicine use between patients with skin cancer and inflammatory skin diseasesF Amatore, S Devey, C Tabelé, et al.
Annales De Dermatologie Et De Venereologie|February 13, 2021
Which adjuvant treatment for patients with BRAF<sup>V600</sup>-mutant cutaneous melanoma?E Funck-Brentano, N Malissen, A Roger, et al.
La Revue De Medecine Interne|August 22, 2021
[Minimal change nephropathy and IgA deposits associated with a Sezary syndrome]A Bichon, A Brue, R Godefroy, et al.
European Journal of Cancer (Oxford, England : 1990)|August 8, 2017
Survival of melanoma patients treated with targeted therapy and immunotherapy after systematic upfront control of brain metastases by radiosurgeryC Gaudy-Marqueste, A S Dussouil, R Carron, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 9, 2025
Neoadjuvant intralesional targeted immunocytokines (daromun) in stage III melanomaK C Kähler, J C Hassel, M Ziemer, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Annales De Dermatologie Et De Venereologie|May 20, 2014
[Multiple primary cutaneous plasmacytoma]N Malissen, C Fabre, J-M Joujoux, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 8, 2019
Comparison of complementary and alternative medicine use between patients with skin cancer and inflammatory skin diseasesF Amatore, S Devey, C Tabelé, et al.
Annales De Dermatologie Et De Venereologie|February 13, 2021
Which adjuvant treatment for patients with BRAF<sup>V600</sup>-mutant cutaneous melanoma?E Funck-Brentano, N Malissen, A Roger, et al.
La Revue De Medecine Interne|August 22, 2021
[Minimal change nephropathy and IgA deposits associated with a Sezary syndrome]A Bichon, A Brue, R Godefroy, et al.
European Journal of Cancer (Oxford, England : 1990)|August 8, 2017
Survival of melanoma patients treated with targeted therapy and immunotherapy after systematic upfront control of brain metastases by radiosurgeryC Gaudy-Marqueste, A S Dussouil, R Carron, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 9, 2025
Neoadjuvant intralesional targeted immunocytokines (daromun) in stage III melanomaK C Kähler, J C Hassel, M Ziemer, et al.
Pageof 1